World Solve

This parasitic disease affects millions in tropical and subtropical regions, but effective treatment remains expensive, difficult to access, or logistically challenging for many affected communities. Closing this access gap remains unresolved.

Malnutrition rates spike dramatically in areas affected by war, but delivering treatment consistently in unstable, hard-to-reach regions remains a persistent logistical and medical challenge. Solving this requires both medical and access innovation.

Highly effective hepatitis C treatments exist, but cost and healthcare access still prevent many infected people worldwide from receiving them. Expanding affordable access remains the primary barrier rather than the science itself.

Cervical cancer remains highly preventable through regular screening, but many women in lower-resource regions lack consistent access to the tests that catch it early. Closing this access gap could prevent large numbers of otherwise preventable deaths.

Effective vaccines exist for a small number of sexually transmitted infections, but many common ones still have no vaccine available at all. Expanding vaccine coverage here could significantly reduce global disease burden.

Effective treatments for hepatitis B exist, but cost and access remain out of reach for many of the hundreds of millions of people living with the infection globally, particularly in lower-income regions. Closing this access gap remains unresolved.

Chronic skin conditions often require lifelong management with creams and medications rather than a resolution of the underlying immune or genetic causes. A real cure, rather than continuous symptom control, remains unavailable.

Drug-resistant tuberculosis requires longer, more expensive, and more toxic treatment regimens that many patients in affected regions simply can't access or complete. This keeps a preventable disease deadly in the parts of the world least equipped to fight it.

Lung cancer screening guidelines are generally built around smoking history, but a meaningful share of cases occur in people who never smoked at all and often go undetected until later stages. Better screening approaches for this group remain underdeveloped.

Severe burn victims often face long, painful recoveries and permanent scarring because lab-grown skin grafts aren't yet fast or effective enough to fully replace damaged tissue. Faster, better regeneration methods could change burn treatment entirely.

Ovarian cancer is often called a silent disease because symptoms don't appear until it has advanced significantly. Early detection tools remain far behind those available for other common cancers.

Emerging gene therapies show promise but remain extremely expensive and inaccessible to the vast majority of people living with sickle cell disease worldwide, especially in Africa where it's most common. Making a real cure affordable and available remains unsolved.

Warring factions sometimes restrict aid access as a tactic, leaving civilians without food, medicine, or shelter even when help is nearby and available. International governance has struggled to guarantee safe humanitarian access consistently.

Undiagnosed vision problems in children can quietly affect school performance for years before being caught. Early, affordable screening at scale remains unavailable in many school systems worldwide.

A meaningful share of people who contracted COVID-19 continue experiencing fatigue, brain fog, or other symptoms long after recovery, with no reliably effective treatment yet available. This remains a significant and only partially understood health burden.

Clothing production involves water use, chemical dyes, and labor spread across many countries, making its full environmental cost difficult to measure accurately. Without clear measurement, meaningful accountability remains difficult to enforce.

Overgrazing and development have degraded vast grassland ecosystems worldwide, and restoration efforts remain small compared to the scale of the damage. A more scalable restoration method could recover important habitat and carbon storage.

Allowing payment for organs or surrogacy could increase availability and help people in need, but also raises concerns about exploitation of the poor. Society remains deeply divided on where ethical limits should sit.

Small businesses often struggle to access recovery funding quickly enough after disasters, leading to permanent closures that could have been prevented. Faster, more accessible recovery financing remains an unresolved gap.

Caregiving and household labor, disproportionately done by women, largely goes uncounted in standard economic measures like GDP. This makes an enormous amount of real economic contribution effectively invisible in policy decisions.